Pure Global

Immediate confirmation of the cell membrane glycoprotein receptor IIb/IIIa assay set - Taiwan Registration fed137af865e594edb20ca9bc2e509f7

Access comprehensive regulatory information for Immediate confirmation of the cell membrane glycoprotein receptor IIb/IIIa assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number fed137af865e594edb20ca9bc2e509f7 and manufactured by ACCUMETRICS, INC.. The authorized representative in Taiwan is MEDDRAGON TECHNOLOGY CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
fed137af865e594edb20ca9bc2e509f7
Registration Details
Taiwan FDA Registration: fed137af865e594edb20ca9bc2e509f7
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Immediate confirmation of the cell membrane glycoprotein receptor IIb/IIIa assay set
TW: 立即確認 細胞膜醣蛋白接受器 IIb/IIIa檢測試劑組
Risk Class 2
Cancelled

Registration Details

fed137af865e594edb20ca9bc2e509f7

DHA00602195104

Company Information

United States

Product Details

立即確認 細胞膜醣蛋白接受器 IIb/IIIa檢測試劑組是一種半定量式全血中血小板功能檢測,測量病人以abciximab或eptifibatide治療後細胞膜醣蛋白接受器 IIb/IIIa的阻斷情形. 臨床醫師於判讀VerifyNow IIb/IIIa assay時應該配合其他臨床與實驗室數據.

B Hematology, pathology, and genetics

B.5700 Automated platelet agglutination system

import

Dates and Status

Mar 03, 2011

Mar 03, 2016

May 17, 2018

Cancellation Information

Logged out

許可證已逾有效期